we're not just a stock market game
Sign up free
Athersys Inc (ATHX)
Athersys is a biopharmaceutical company developing treatment options for ailments such as obesity and cardiovascular disease
Events
-
June202012Athersys, Inc., Annual General Meeting, Jun 20, 2012
-
August 62012Athersys, Inc. expected to report Q2 2012 results on August 6, 2012. This event was calculated by Capital IQ (Created on May 16, 2012).
-
March112013Athersys, Inc. expected to report Fiscal Year 2012 results on March 11, 2013. This event was calculated by Capital IQ (Created on March 29, 2012).
Members who own this company also own
$1.40
Current price per share
Today's gain: $0.01 (0.73%)
Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
